product summary
Loading...
company name :
MyBioSource
product type :
protein
product name :
MDM4 (1-137) recombinant protein
catalog :
MBS515348
quantity :
0.02 mg
price :
260 USD
more info or order :
product information
catalog number :
MBS515348
products type :
Recombinant Protein
products full name :
MDM4 (1-137) recombinant protein
products short name :
MDM4
products name syn :
DKFZp781B1423; HDMX; MDMX; MGC132766; MRP1; MDM4(1-137) Protein
other names :
Homo sapiens Mdm4 p53 binding protein homolog (mouse) (MDM4), transcript variant 1, mRNA; Protein Mdm4; protein Mdm4; protein Mdmx; MDM4-related protein 1; mdm2-like p53-binding protein; double minute 4, human homolog of; p53-binding protein; Mdm4 p53 binding protein homolog (mouse); Double minute 4 protein; Mdm2-like p53-binding protein; Protein Mdmx; p53-binding protein Mdm4
products gene name :
MDM4
products gene name syn :
DKFZp781B1423; HDMX; MDMX; MGC132766; MRP1
other gene names :
MDM4; MDM4; HDMX; MDMX; MRP1; MDMX
uniprot entry name :
MDM4_HUMAN
host :
E Coli
sequence positions :
1-137
sequence length :
10090
purity :
>75%
form :
50mM sodium phosphate, pH 7.0, 300mM NaCl, 150mM imidazole, 0.1mM PMSF, 0.25mM DTT, 25% glycerol.
concentration :
0.2 ug/ul
storage stability :
Store product at -70 degree C. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles. STable for 1 year at -70 degree C from date of shipment.
tested application :
Western Blot (WB)
other info1 :
Type: Recombinant Fusion Protein. Species: Human. Tag Information: His tag. Expression System: E.coli. Source Note: Recombinant human MDM4 (1-137) was expressed in E. coli cells
products categories :
Cell Cycle Proteins; Signaling Proteins - Cell Cycle Proteins
products description :
Recombinant human MDM4 (1-137) was expressed in E. coli cells using an N-terminal His tag. Scientific Background: MDM4 is a nuclear protein that contains a p53 binding domain at the N-terminus and a RING finger domain at the C-terminus. MDM4 shows structural similarity to p53-binding protein MDM2 and both proteins bind the p53 tumor suppressor protein and inhibit its activity. However, unlike MDM2, MDM4 does not cause nuclear export or degradation of p53. Instead, MDM4 inhibits p53 activity by binding to the transcriptional activation domain of p53. MDM4 is overexpressed in a variety of human cancers (1). Expression level of MDM4 is significantly higher in chronic lymphocytic leukemia. MDM4 is a specific chemotherapeutic target for treating retinoblastoma (2).
products references :
1. Parant, J.et.al: Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nature Genet. 29: 92-95, 2001. 2. Laurie, N. A. et.al: Inactivation of the p53 pathway in retinoblastoma. Nature 444: 61-66, 2006.
ncbi gi num :
323510631
ncbi acc num :
NP_002384.2
ncbi gb acc num :
NM_002393
uniprot acc num :
O15151
ncbi mol weight :
~17.3 kDa
ncbi pathways :
MicroRNAs In Cancer Pathway (852705); MicroRNAs In Cancer Pathway (852928); Signaling Pathways In Glioblastoma (672458); P53 Pathway (138067); P53 Signaling Pathway (83055); P53 Signaling Pathway (465)
ncbi summary :
This gene encodes a nuclear protein that contains a p53 binding domain at the N-terminus and a RING finger domain at the C-terminus, and shows structural similarity to p53-binding protein MDM2. Both proteins bind the p53 tumor suppressor protein and inhibit its activity, and have been shown to be overexpressed in a variety of human cancers. However, unlike MDM2 which degrades p53, this protein inhibits p53 by binding its transcriptional activation domain. This protein also interacts with MDM2 protein via the RING finger domain, and inhibits the latter's degradation. So this protein can reverse MDM2-targeted degradation of p53, while maintaining suppression of p53 transactivation and apoptotic functions. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Feb 2011]
uniprot summary :
Function: Inhibits p53/TP53- and TP73/p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Inhibits degradation of MDM2. Can reverse MDM2-targeted degradation of TP53 while maintaining suppression of TP53 transactivation and apoptotic functions. Ref.9 Ref.10. Subunit structure: Interacts with MDM2, TP53, TP73 and USP2. Found in a trimeric complex with UPB2, MDM2 and MDM4. Interacts (phosphorylated) with YWHAG; negatively regulates MDM4 activity toward TP53. Ref.9 Ref.10 Ref.11. Subcellular location: Nucleus. Tissue specificity: Expressed in all tissues tested with high levels in thymus. Induction: Down-regulated by cisplatin (at protein level). Ref.11. Domain: Region I is sufficient for binding TP53 and inhibiting its G1 arrest and apoptosis functions. It also binds TP73. Region II contains most of a central acidic region and a putative C4-type zinc finger. The RING finger domain which coordinates two molecules of zinc mediates the heterooligomerization with MDM2. Post-translational modification: Phosphorylated. Phosphorylation at Ser-367 promotes interaction with YWHAG and subsequent ubiquitination and degradation. Phosphorylation at Ser-342 also induces ubiquitination and degradation but to a lower extent. Ref.9 Ref.10Ubiquitinated and degraded by MDM2. Deubiquitination by USP2 on the other hand stabilizes the MDM4 protein. Ref.9 Ref.11. Sequence similarities: Belongs to the MDM2/MDM4 family.Contains 1 RanBP2-type zinc finger.Contains 1 RING-type zinc finger.Contains 1 SWIB domain. Mass spectrometry: Molecular mass is 54863.3 Da from positions 1 - 490. Determined by MALDI. Ref.12
size1 :
0.02 mg
price1 :
260 USD
size2 :
0.05 mg
price2 :
415
more info or order :
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!